Navigation Links
Obesity And Overweight Linked To Definite Cancer Risk

A new research conducted by the American Institute for Cancer Research (AICR), has now concluded that fat cells function like endocrine cells, secreting hormones and other growth factors into the blood. // This has for the first time changed the popular belief that fat is an inert substance.

In individuals with a normal weight, physiological levels of these hormones and growth factors play a major role in the regulation of metabolism and other body processes. However in obese individuals, excess amounts of these substances are secreted and can trigger the abnormal growth and differentiation of cells, leading to tumor.

It is believed that frequent cell division and replication could increase cancer risk, as the probability of a random mutation occurring is very high. Nearly 3.2% of all new cancers in 2002 were found to be related to obesity according to an estimate by United States National Cancer Institute (NCI).

A recent report published has revealed alarming results that obesity can account for 14% and 20% of all cancer related deaths in men and women respectively. From a large pool of data currently available, obesity has been found to correlate with increased risk (25-30%) for cancer of the colon, breast, endometrium (uterus), kidney and esophagus. Some less commonly associated tumors are that of the gallbladder, ovaries and pancreas.

Weight reduction seems the only sensible solution to prevent the incidence of obesity related tumors and other chronic diseases such as diabetes, hypertension, heart attack and stroke.

Don’t be waiting to frame a New Year resolution as even a 5-10% loss in weight can provide innumerable health benefits according to scientific experts. Any day is good day to start your weight reduction regime.


'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity raises IVF miscarriage risk
3. Obesity a risk for pancreatic cancer
4. Obesity shortens lifespan
5. Is Obesity a risk factor?
6. Obesity a global problem
7. Obesity increases health costs
8. Obesity in children a risk factor for diabetes
9. Decrease of Hunger Hormone after Obesity Surgery
10. Obesity risk for immobilized adults
11. Obesity risk can be reduced by eating breakfast regularly
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: